LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS TREATED FOR INFLAMMATORY BOWEL DISEASE

医学 硫嘌呤甲基转移酶 淋巴瘤 炎症性肠病 内科学 入射(几何) 溃疡性结肠炎 药店 小儿胃肠病 疾病 儿科 家庭医学 光学 物理
作者
Matthew D. Egberg,Xian Zhang,Andrew B Smitherman,Michael D Kappelman
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:Publish Ahead of Print
标识
DOI:10.14309/ajg.0000000000002053
摘要

Despite the effectiveness of immune suppressing therapies in treating pediatric inflammatory bowel diseases (IBD), concerns of lymphoma may limit their use. We used a large administrative claims database to evaluate the risk of lymphoma in pediatric IBD and conducted a case series analysis of medication exposure in children diagnosed with lymphoma.We analyzed administrative claims from the 2007-2018 IQVIA database and identified pediatric (≤18 years) patients with Crohn's disease (CD), or ulcerative colitis (UC) using ICD-9/10 codes and pharmacy claims. Lymphoma cases were identified by diagnosis codes and confirmed by independent, claim-by-claim review by a pediatric oncologist and gastroenterologist. We calculated incidence rates (IR) for lymphoma among patients with and without pharmacy claims for treatment followed by treatment description among those who developed lymphoma during follow-up.A total of 10,777 pediatric IBD patients received ≥1 IBD therapy (median age 15 years (12,17), 45% female and 61% diagnosed with CD) during 28,292 patient-years of follow up. Among treated patients, five lymphoma cases were identified (IR 17.7/100,000 patient-years; 95% CI 6.5, 39.2). Of these, 4 four were treated with a thiopurine prior to lymphoma diagnosis and none received anti-TNF monotherapy.The overall lymphoma incidence was low among our cohort of treated pediatric IBD patients. We observed no cases of lymphoma among patients prescribed anti-TNF monotherapy. These findings reinforce the relative safety of anti-TNF monotherapy for the treatment of pediatric IBD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
WEIWEI完成签到,获得积分10
1秒前
2秒前
3秒前
小小发布了新的文献求助10
3秒前
顾矜应助李长印采纳,获得10
3秒前
3秒前
4秒前
4秒前
量子星尘发布了新的文献求助10
5秒前
直率的惜寒完成签到,获得积分10
6秒前
7秒前
爱莉希雅发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
情怀应助笨笨山芙采纳,获得10
10秒前
小白发布了新的文献求助10
11秒前
12秒前
小二郎应助科研通管家采纳,获得10
12秒前
核桃应助科研通管家采纳,获得10
12秒前
Lucas应助科研通管家采纳,获得10
12秒前
领导范儿应助科研通管家采纳,获得10
12秒前
12秒前
在水一方应助科研通管家采纳,获得10
12秒前
ludov应助科研通管家采纳,获得10
12秒前
JamesPei应助科研通管家采纳,获得10
12秒前
555557发布了新的文献求助10
12秒前
怡然乌应助科研通管家采纳,获得10
12秒前
坦率的匪应助科研通管家采纳,获得10
12秒前
JamesPei应助科研通管家采纳,获得10
12秒前
坦率的匪应助科研通管家采纳,获得10
12秒前
12秒前
13秒前
13秒前
旺仔完成签到,获得积分10
14秒前
14秒前
端庄的萝发布了新的文献求助20
15秒前
YZQ发布了新的文献求助10
17秒前
tao发布了新的文献求助10
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035